Israel Canada Hotels

ICHO.TA

Travel Lodging · Consumer Cyclical

Price

103.70 ILA

+1.20 (+1.17%)

Market Cap

931.5M ILA

Exchange

Tel Aviv Stock Exchange

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.

Data as of Sep 1, 2026 · filings through Mar 31, 2026

How the score breaks down

Quality

Weak

Growth

Mixed

Cash Flow

Weak

Stability

Weak

Valuation

Data not available

Track this stock — start free trial

Share count rising — dilution

+690.2% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 88.2M (2021) → 697.2M (2025)

Winston Score History

The full picture

Israel Canada Hotels Ltd, operating through its various subsidiaries, is globally involved in the creation, production, and distribution of patented ultrasound technology. These advanced systems are instrumental in assessing bone strength and density, alongside tracking calcium loss, especially for diagnosing osteoporosis in both adults and children. Beyond its medical device activities, the company also engages in the development of oral pharmaceuticals. Incorporated in 2004 and based in Tel Aviv, Israel, the entity, which was previously known as Dna Group (T.R.) Ltd, is set to formally adopt the name Israel Canada Hotels Ltd in November 2025.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

>+1,000% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-514.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

0 ILS/ year

0.0% of revenue

Below sector average (4%)

Research and development spending

Cash Runway

~3 years

518M ILS cash & investments

518M ILS cash & investments at current burn rate

Revenue accelerating

Israel Canada Hotels grew revenue 65391% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

17.0%

Thin — 17.0% gross margin

Profit after running costs

Operating Margin

-2.8%

Losing money on operations — -2.8%

Return on the money invested

ROCE

-0.9%

Weak — -0.9% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

>+1,000%

Fast-growing sales (>+1,000% YoY)

Profit growth

EPS YoY

-464.4%

Earnings shrinking (-464.4% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is

EPS Consistency

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-17.7%

Burning cash (-17.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

1.45

Elevated debt (1.45)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial